Doceree Launches AI-Powered Insights for Pharma Marketers

The newly launched tool leverages AI and natural language processing (NLP) to interpret and understand the questions of pharma marketers and provide suitable answers.

Doceree, a healthcare startup, has launched an AI-powered tool called “Insights” for healthcare marketers. This tool simplifies analytics by allowing pharma marketers to ask business-related questions and receive answers in the form of interactive, exportable data visualisations.

The newly launched tool leverages AI and natural language processing (NLP) to interpret and understand the questions of pharma marketers and provide suitable answers.

Moreover, it also allows users to export and incorporate the data and visualisations into their own branded presentations, making it easier for pharma marketers to tell their stories with data.

The aim of this AI-powered tool is to analyse and interpret large amounts of data to provide actionable insights. It further seeks to answer questions quickly and easily without requiring advanced analytical skills. The tool can transform complex and fragmented data into actionable insights with just a click of a button.

Sharing his views, Harshit Jain MD, founder and global CEO, Doceree, said, "Doceree is committed to finding the bottlenecks in pharma messaging and bridging them with its Al-powered, category-focused platform and end-to-end solutions that allow pharma marketers to activate top-performing campaigns, while also effectively tracking their KPIs. With our new offering Insights, we are set to revolutionise healthcare marketing analytics, making data-driven decisions for pharma marketers, as easy as asking a question."

Founded in 2019, by Daleep Manhas and Harshit Jain, Doceree is a healthcare marketing technology company. It provides marketing solutions for pharmaceutical and healthcare brands to connect with healthcare professionals (HCPs).

Recently in an interview with DHN, Harshit Jain, cofounder of Doceree said that the platform's integrated and collaborative ecosystem enables pharmaceutical brands and digital platforms to leverage uncharted opportunities within the life sciences marketing landscape in the most organised manner possible.

With Doceree, Rx drug marketers can promote their drugs in a customised format to the targeted healthcare professionals while providing an opportunity for digital platforms to generate decent revenue. Going forward, Doceree plans to continue its growth and advancement in the healthcare marketing technology sector.

In another instance, Google DeepMind unveiled an AI tool to predict harmful genetic mutations. The tool, named AlphaMissense, focuses on 'missense' mutations, which involve a single letter of the genetic code. The human genome typically contains around 9,000 of these mutations, some of which can be benign, while others can lead to diseases such as cystic fibrosis and cancer or affect brain development.